The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and anti-hormonal compounds, such as anti-estrogens.
US Patent 07498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compoundsUS Patent 7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds